Barclays PLC Immutep LTD Transaction History
Barclays PLC
- $436 Billion
- Q2 2025
A detailed history of Barclays PLC transactions in Immutep LTD stock. As of the latest transaction made, Barclays PLC holds 16 shares of IMMP stock, worth $33. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16
Previous 16
-0.0%
Holding current value
$33
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IMMP
# of Institutions
30Shares Held
1.92MCall Options Held
19.3KPut Options Held
27.3K-
Black Rock Inc. New York, NY839KShares$1.74 Million0.0% of portfolio
-
Meridian Wealth Management, LLC373KShares$771,4880.03% of portfolio
-
Sender CO & Partners, Inc. New York, NY123KShares$254,1000.11% of portfolio
-
Morgan Stanley New York, NY119KShares$247,2940.0% of portfolio
-
Ubs Group Ag64.8KShares$134,2220.0% of portfolio
About IMMUTEP Ltd
- Ticker IMMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,000
- Market Cap $179M
- Description
- Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...